OptimizeRx Corp (OPRX) stock
OPRXNasdaqServices-Business Services, NECFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 10/3030% below fair value
$6.94+0.30 (+4.52%)
Close on Nov 17, 2026Market cap $130.72MP/E 28.9Yield –
OptimizeRx operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
OptimizeRx's operating cash flow for the twelve months ending Jun 30, 2026 was $18.43M, up 77.0% year over year. For fiscal 2025 it was $18.72M, up 282.8% from the year before. Over ten years it grew 43.2% a year on average. The highest annual figure on record is $18.72M in fiscal 2025.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $18.72M | +282.8% |
| FY2024 | Dec 31, 2024 | $4.89M | – |
| FY2023 | Dec 31, 2023 | -$7.24M | -168.0% |
| FY2022 | Dec 31, 2022 | $10.65M | +1367.4% |
| FY2021 | Dec 31, 2021 | $726.04K | – |
| FY2020 | Dec 31, 2020 | -$6.31M | – |
| FY2019 | Dec 31, 2019 | -$1.66M | -309.5% |
| FY2018 | Dec 31, 2018 | $792.56K | – |
| FY2017 | Dec 31, 2017 | -$1.48M | – |
| FY2016 | Dec 31, 2016 | -$465.97K | -190.5% |
| FY2015 | Dec 31, 2015 | $515.11K | – |
| FY2014 | Dec 31, 2014 | -$56.35K | -105.0% |
| FY2013 | Dec 31, 2013 | $1.13M | – |
| FY2012 | Dec 31, 2012 | -$624.03K | – |
| FY2011 | Dec 31, 2011 | -$521.51K | – |
| FY2010 | Dec 31, 2010 | -$1.31M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $8.61M | +88.8% |
| Q1 FY2026 | Mar 31, 2026 | -$467.00K | -112.1% |
| Q4 FY2025 | Dec 31, 2025 | $7.09M | +3479.8% |
| Q3 FY2025 | Sep 30, 2025 | $3.20M | +78.8% |
| Q2 FY2025 | Jun 30, 2025 | $4.56M | +483.2% |
| Q1 FY2025 | Mar 31, 2025 | $3.86M | +82.4% |
| Q4 FY2024 | Dec 31, 2024 | $198.00K | – |
| Q3 FY2024 | Sep 30, 2024 | $1.79M | +21.6% |
| Q2 FY2024 | Jun 30, 2024 | $782.00K | – |
| Q1 FY2024 | Mar 31, 2024 | $2.12M | – |
| Q4 FY2023 | Dec 31, 2023 | -$6.26M | -323.2% |
| Q3 FY2023 | Sep 30, 2023 | $1.47M | -63.9% |
| Q2 FY2023 | Jun 30, 2023 | -$2.37M | – |
| Q1 FY2023 | Mar 31, 2023 | -$86.00K | -142.0% |
| Q4 FY2022 | Dec 31, 2022 | $2.80M | +1376.3% |
| Q1 FY2022 | Mar 31, 2022 | $4.08M | +144.9% |
| Q4 FY2021 | Dec 31, 2021 | -$1.33M | – |
| Q3 FY2021 | Sep 30, 2021 | $204.93K | – |
| Q2 FY2021 | Jun 30, 2021 | $189.90K | +48.8% |
| Q1 FY2021 | Mar 31, 2021 | $1.67M | – |
| Q4 FY2020 | Dec 31, 2020 | -$2.59M | – |
| Q3 FY2020 | Sep 30, 2020 | -$106.60K | -112.0% |
| Q2 FY2020 | Jun 30, 2020 | $127.64K | -86.3% |
| Q1 FY2020 | Mar 31, 2020 | -$3.74M | -446.6% |
| Q2 FY2019 | Jun 30, 2019 | -$81.77K | – |
| Q1 FY2019 | Mar 31, 2019 | $889.97K | – |
| Q4 FY2018 | Dec 31, 2018 | $932.76K | +17803.3% |
| Q3 FY2018 | Sep 30, 2018 | $1.08M | – |
| Q2 FY2018 | Jun 30, 2018 | -$431.47K | – |
| Q1 FY2018 | Mar 31, 2018 | -$787.39K | – |
| Q4 FY2017 | Dec 31, 2017 | $5.21K | – |
| Q3 FY2017 | Sep 30, 2017 | -$788.95K | -721.9% |
| Q2 FY2017 | Jun 30, 2017 | -$398.86K | -466.9% |
| Q1 FY2017 | Mar 31, 2017 | -$297.24K | – |
| Q4 FY2016 | Dec 31, 2016 | -$415.44K | – |
| Q3 FY2016 | Sep 30, 2016 | $126.86K | – |
| Q2 FY2016 | Jun 30, 2016 | $108.71K | – |
| Q1 FY2016 | Mar 31, 2016 | -$286.09K | – |
See a number that looks wrong?